Cancer therapies: How we link drug sensitivity to molecular profiling to identify biomarkers

23-03-2018

Professor Krister Wennerberg talks on stratified cancer therapies and their predictive biomarkers at the Oncology Network meeting April 9th.

Cancer therapies: How we link drug sensitivity to molecular profiling to identify biomarkers

Biopeople/Biomarkers as emerging growth area joins forces with Medicon Valley Alliance on April 9th and invites members to the MVA Oncology Networks 5th meeting covering the topic “Biomarkers – opportunities and challenges in oncology drug development”:

The keynote and scoop of the day is Professor Krister Wennerberg who will talk on “Systems medicine methods for identification of stratified cancer therapies and their predictive biomarkers".

“I will describe how we combine comprehensive drug sensitivity testing with molecular profiling on primary cancer cells to identify and understand stratified drug vulnerabilities and study how this information may translate to the patient. While the ex vivo drug responses can be seen as functional biomarkers, they are challenging to apply in clinical practice and I will describe how we link the drug sensitivity testing to molecular profiling information to identify predictive biomarkers," says Krister Wennerberg to the Biopeople Newsletter

BIO:
From 2017, Krister Wennerberg works as Professor and Group Leader at Biotech Research & Innovation Centre (BRIC), University of Copenhagen. Krister Wennerberg Krister Wennerberg received his Ph.D. in biochemistry from Uppsala University, Sweden and had his postdoctoral training at the University of North Carolina at Chapel Hill, USA. Following his postdoc, he worked as an R&D scientist at Cytoskeleton, Inc. and as an assay development group leader at Southern Research Institute in Birmingham, AL, USA. From 2010, he joined FIMM, Institute for Molecular Medicine Finland.

Read more on the event

Latest news

Overwhelming interest from leading speakers in First Nordic conference on personalized medicine 11-04-2018
The conference in Nyborg looks mainly at the underlying mechanisms causing variability in clinical response and drug toxicity. We talked to organizer...
Cancer therapies: How we link drug sensitivity to molecular profiling to identify biomarkers 23-03-2018
Professor Krister Wennerberg talks on stratified cancer therapies and their predictive biomarkers at the Oncology Network meeting April 9th.
Biopeople i nyt samarbejde med magasinet Life Science 22-03-2018
I 2018 har Biopeople indgået et samarbejde med bladet Life Science – Dansk Biotek (in Danish only).
Call: USA East Coast Innovation Tour - Greater Boston & Greater New York - deadline March 30th 21-03-2018
The Innovation Tour is specifically focused on life science companies from Europe to explore research, commercialization and investment opportunities...
Internationalt uddannelsessamarbejde inden for regulering af medicin 20-03-2018
Den 27. februar 2018 arrangerede Biopeople og Copenhagen Centre for Regulatory Science en international workshop for mere end 25 unge forskere fra...

Related

Close
What are you looking for?
This site uses the functionality that older versions of Internet Explorer does not support. You should therefore switch or upgrade your browser.